Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 8/2/2025Sumitomo Pharma Completes Divestiture of China Business to Marubeni Gr...
  • 8/2/2025China's Innovative Drug Market Surpasses CNY 400 Billion, Commercial M...
  • 8/2/2025Attec Secures Strategic Series A Funding to Advance Protein Degrader P...
  • 8/1/2025Chipscreen's Brain-Penetrant Aurora B Selective Inhibitor Receives FDA...
  • 8/1/2025Shanghai UTC Therapeutics Secures FDA IND Clearance for Novel MSLN CAR...
  • 8/1/2025Mabgeek Clinches CNY 260M Pre‑IPO Boost and Advances MG‑K10 Commerc...
  • 8/1/2025TenNor Therapeutics IPO Application Accepted by HKEX
  • 8/1/2025Lepu Biopharma Licenses Two T‑Cell Engagers to Excalipoint
  • 8/1/2025Everest Makes Strategic Equity Investment in I-Mab to Advance Oncology...
  • 8/1/2025Arrowhead Subsidiary Visirna Sells Rights to Hypertriglyceridemia Cand...
  • 8/1/2025China's Biotech Sector Faces Geopolitical Headwinds as Asia-Pacific Em...
  • 8/1/2025Wuxi AppTec Raises Nearly US$1B in Hong Kong to Fuel Global Expansion
  • 8/1/2025India Moves to Set Minimum Import Prices to Protect Pharma Sector from...
  • 7/31/2025China Seeks Feedback on Draft Guidelines for Eosinophilic Esophagitis ...
  • 7/31/2025China Sees Surge in Drug Applications: 24 New Therapies Filed with NMP...
  • 7/31/2025Lee’s Subsidiary Wins Approval of Socazolimab for ES‑SCLC in China
  • 7/31/2025Alphamab's JSKN003 Wins Orphan and BTD Designations in Two Major Marke...
  • 7/31/2025DarwinCell Breaks Ground with CNY 200M Series C Financing from Tsing C...
  • 7/31/2025Ancocare Closes Series B Financing to Fuel Oncolytic Virus Pipeline E...
  • 7/31/2025Leto Lab Secures Series D Financing Led by Hankang Capital
  • 7/31/2025R&B Bio Secures New Funding Round Led by SBI Holdings
  • 7/31/2025China's 'Silver Yuan' Set to Power US$134B Boom in Geriatric Healthcar...
  • 7/31/2025GE HealthCare Q2 Results Highlight Mixed Signals in China Amid Tariff ...
  • 7/31/2025U.S. Closes Bribery Investigation into GE Healthcare's China Operation...
  • 7/30/2025CDE Issues Technical Guidelines on Drug Exposure–Response Relationshi...
  • 7/30/2025CDE Releases New Guidelines on Impurity Limits for Fermentation or Sem...
  • 7/30/2025CDE Issues New Guidance on Clinical Pharmacology Research for Rare Dis...
  • 7/30/2025CDE Issues Technical Guidance on Model-Informed Drug Development for R...
  • 7/30/2025AstraZeneca's Lynparza Gains Approval for New Indication in China
  • 7/30/2025J&J's Lazcluze Approved for NSCLC in China
  • Page:16/59 Total number of articles:1741: [First][<<] [14] [15] [16] [17] [18] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group